临床淋巴结阴性早期乳腺癌前瞻性腋窝手术降阶试验中腋窝超声方案的差异
本叙述性综述比较了临床淋巴结阴性(cN0)早期乳腺癌保乳治疗中比较前哨淋巴结活检与完全省略前哨淋巴结活检的前瞻性降阶试验,重点分析腋窝超声方案。共纳入1项已发表和3项正在进行的前瞻性试验,患者数1405至5505例,各试验在是否纳入腋窝超声可疑且超声引导活检阴性患者、皮质厚度截断值(2.3 mm至3.0 mm)及超声引导活检技术方面存在差异。作者认为腋窝超声方案需要统一以改善试验结果的外推性。
要点
- 各试验腋窝超声皮质厚度截断值范围为2.3 mm至3.0 mm。
- 试验间是否纳入腋窝超声可疑但超声引导活检阴性的患者存在差异。
- 各试验采用的超声引导活检技术(细针穿刺或空芯针活检)不同。
核心结论
- 临床淋巴结阴性早期乳腺癌保乳治疗的前瞻性腋窝手术降阶试验在腋窝超声方案和超声引导活检技术方面存在差异;腋窝超声方案需要统一以改善这些试验结果的外推性。
研究设计与样本
- 叙述性综述,纳入1项已发表和3项正在进行的前瞻性降阶腋窝手术分期试验,比较前哨淋巴结活检与完全省略前哨淋巴结活检,患者数范围为1405至5505例,对象为接受保乳治疗的cT1/2N0患者。
诊断标准与关键数值
- 各试验腋窝超声皮质厚度截断值范围为2.3 mm至3.0 mm。
- 各试验在是否纳入腋窝超声可疑且超声引导活检阴性的患者方面存在差异。
- 各试验采用不同的超声引导活检技术,包括细针穿刺或空芯针活检。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Surgical axillary staging of the axilla is a topic of debate regarding the potential of de-escalation in clinically node negative (cN0) early breast cancer patients treated with breast-conserving therapy. Axillary ultrasound is important to determine clinical nodal status. The aim of the current narrative review is to provide an overview of prospective trials on de-escalating axillary surgical staging in cN0 early breast cancer patients, with an emphasis on axillary ultrasound protocols.
METHODS: This narrative review provides an overview of the prospective de-escalating axillary surgical staging trials, in terms of comparing sentinel lymph node biopsy (SLNB) versus complete omission of SLNB, in cT1/2N0 patients treated with breast-conserving therapy. Information from each trial was collected, including reported axillary ultrasound protocols (including cortical thickness cut-off value) and axillary ultrasound-guided biopsy technique (fine-needle aspiration or core-needle biopsy).
RESULTS: There is one recently published prospective trial and three ongoing prospective trials within the topic of this narrative review. Number of included patients in these trials ranges from 1405 to 5505 patients. The included trials differed whether or not to include patients with suspicious axillary ultrasound findings and a negative ultrasound-guided biopsy. Cortical thickness cut-off value ranged from 2.3 mm to 3.0 mm. Different ultrasound-guided biopsy techniques were performed among the included trials.
CONCLUSION: Prospective de-escalating axillary surgical staging trials in clinically node negative early breast cancer patients treated with breast-conserving therapy do report differences in terms of axillary ultrasound protocols and ultrasound-guided biopsy techniques. Axillary ultrasound protocols do require uniformity in order to improve extrapolation of these trial results.
引用
- van Nijnatten TJA, Poplack SP, Wijgers RA, et al. Differences in axillary ultrasound protocols among prospective de-escalating axillary surgical staging trials in clinically node negative early breast cancer patients. Eur J Radiol. 2024. PMID: 39369617. doi:10.1016/j.ejrad.2024.111775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。